Update: Recommendations for Diagnosis of Shiga Toxin-Producing Escherichia coli Infections by Clinical Laboratories

Clinical Microbiology Newsletter

Volumn 34, Issue 10, 2012, Pages 75-83

  Gould, L Hannah ^a   Bopp, C ^a   Strockbine, N ^b   Atkinson, R ^b   Baselski, V ^b   Body, B ^b   Carey, R ^b   Crandall, C ^b   Hurd, S ^b   Kaplan, R ^b   Neill, M ^b   Shea, S ^b   Somsel, P ^b   Tobin D'Angelo, M ^b   Griffin, P M ^b   Gerner Smidt, P ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ANALYTICAL EQUIPMENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL LABORATORY; COMMUNICABLE DISEASE; CULTURE MEDIUM; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIARRHEA; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; EPIDEMIC; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FECES ANALYSIS; FOOD AND DRUG ADMINISTRATION; HEMATOCHEZIA; HUMAN; LABORATORY DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; SAMPLING; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STRAIN DIFFERENCE; TOXIN ANALYSIS; VOLUNTARY REPORTING;

EID: 84860553081     PISSN: 01964399     EISSN: 18734391     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2012.04.004     Document Type: Article

References (82)

1. Scallan E., et al. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 2011, 17:7-15.
2. Mead P.S., et al. Food-related illness and death in the United States. Emerg. Infect. Dis. 1999, 5:607-625.
3. Johnson K.E., Thorpe C.M., Sears C.L. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 2006, 43:1587-1595.
4. Brooks J.T., et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 2005, 192:1422-1429.
5. Centers for Disease Control and Prevention Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli-Connecticut, 2000-2005. MMWR Morb. Mortal. Wkly. Rep. 2007, 56:29-31.
6. Mead P.S., Griffin P.M. Escherichia coli O157:H7. Lancet 1998, 352:1207-1212.
7. Rowe P.C., et al. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. J. Pediatr. 1998, 132:777-782.
8. Slutsker L., et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann. Intern. Med. 1997, 126:505-513.
9. Manning S.D., et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4868-4873.
10. Ethelberg S., et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg. Infect. Dis. 2004, 10:842-847.
11. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 1998, 11:450-479.
12. Ake J.A., et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005, 115:e673-e680.
13. Centers for Disease Control and Prevention Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis-New York and North Carolina, 2005. MMWR Morb. Mortal. Wkly. Rep. 2006, 55:1042-1045.
14. Bennett W.E., Tarr P.I. Enteric infections and diagnostic testing. Curr. Opin. Gastroenterol. 2009, 25:1-7.
15. Pollock K.G., et al. From diarrhoea to haemolytic uraemic syndrome - when to seek advice. J. Med. Microbiol. 2009, 58:397-398.
16. Klein E.J., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J. Pediatr. 2002, 141:172-177.
17. Cohen M.B. Shiga toxin-producing E. coli: two tests are better than one. J. Pediatr. 2002, 141:155-156.
18. Boerlin P., et al. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 1999, 37:497-503.
19. Jenkins C., et al. Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J. Med. Microbiol. 2003, 52:941-947.
20. Werber D., et al. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:726-730.
21. Ostroff S.M., et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 1989, 160:994-998.
22. Gould L.H., et al. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm. Rep. 2009, 58(RR-12):1-14.
23. Andreoli S.P., et al. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr. Nephrol. 2002, 17:293-298.
24. Begue R.E., et al. A prospective study of Shiga-like toxin-associated diarrhea in a pediatric population. J. Pediatr. Gastroenterol. Nutr. 1994, 19:164-169.
25. Denno D.M., et al. Etiology of diarrhea in pediatric outpatient settings. Pediatr. Infect. Dis. J. 2005, 24:142-148.
26. Klein E.J., et al. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin. Infect. Dis. 2006, 43:807-813.
27. Bokete T.N., et al. Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology 1993, 105:1724-1731.
28. Nataro J.P., et al. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin. Infect. Dis. 2006, 43:402-407.
29. Park C.H., et al. Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital. Diagn. Microbiol. Infect. Dis. 1996, 26:69-72.
30. Gavin P.J., et al. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga toxin-producing E. coli in stool samples. J. Clin. Microbiol. 2004, 42:1652-1656.
31. Kehl K.S., et al. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 1997, 35:2051-2054.
32. Tarr P.I., Gordon C.A., Chandler W.L. Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
33. Jelacic J.K., et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 2003, 188:719-729.
34. Griffin P.M., Olmstead L.C., Petras R.E. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology 1990, 99:142-149.
35. Griffin P.M., et al. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 1988, 109:705-712.
36. Swaminathan B., et al. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg. Infect. Dis. 2001, 7:382-389.
37. DeBoer E., Heuvelink A.E. Methods for the detection and isolation of Shiga toxin-producing Escherichia coli. Symp. Ser. Soc. Appl. Microbiol. 2000, 29:133S-143S.
38. Dundas S., et al. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin. Infect. Dis. 2001, 33:923-931.
39. Guerrant R.L., et al. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 2001, 32:331-351.
40. Shah S., et al. Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center. Clin. Infect. Dis. 1996, 23:835-836.
41. Parry S.M., Salmon R.L. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerg. Infect. Dis. 1998, 4:657-661.
42. Carter A.O., et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N. Engl. J. Med. 1987, 317:1496-1500.
43. Belongia E.A., et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. J. Am. Med. Assoc. 1993, 269:883-888.
44. Ahn C.K., Klein E., Tarr P.I. Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome. Clin. Infect. Dis. 2008, 46:1197-1199.
45. Hedberg C.W., et al. Timeliness of enteric disease surveillance in 6 US states. Emerg. Infect. Dis. 2008, 14:311-313.
46. Smith K.E., et al. Outbreaks of enteric infections caused by multiple pathogens associated with calves at a farm day camp. Pediatr. Infect. Dis. J. 2004, 23:1098-1104.
47. Proctor M.E., et al. Four strains of Escherichia coli O157:H7 isolated from patients during an outbreak of disease associated with ground beef: importance of evaluating multiple colonies from an outbreak-associated product. J. Clin. Microbiol. 2002, 40:1530-1533.
48. Karch H., Tarr P.I., Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 2005, 295:405-418.
49. van Duynhoven Y.T., et al. Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin. Microbiol. Infect. 2008, 14:437-445.
50. Manning S.D., et al. Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg. Infect. Dis. 2007, 13:318-321.
51. Paton A.W., Paton J.C. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J. Clin. Microbiol. 1998, 36:598-602.
52. Bielaszewska M., et al. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin. Infect. Dis. 2008, 47:208-217.
53. Bielaszewska M., et al. Aspects of genome plasticity in pathogenic Escherichia coli. Int. J. Med. Microbiol. 2007, 297:625-639.
54. Tarr P.I., et al. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J. Infect. Dis. 1990, 162:553-556.
55. Olesen B., et al. VTEC O117: K1:H7. A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers. Scand. J. Infect. Dis. 2005, 37:288-294.
56. Bielaszewska M., et al. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?. PLoS ONE. 2007, 2:e1024.
57. Cornick N.A., et al. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J. Infect. Dis. 2002, 186:57-63.
58. Centers for Disease Control and Prevention Clinical laboratory improvement amendments. Subpart K: quality systems for nonwaived testing. Section 493. 1253: Standard; establishment and verification of performance specifications http://wwn.cdc.gov/clia/regs/subpart_k.aspx#493.1253.
59. March S.B., Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol. 1986, 23:869-872.
60. Church D.L., et al. Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory. J. Clin. Microbiol. 2007, 45:3098-3100.
61. Zadik P.M., Chapman P.A., Siddons C.A. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J. Med. Microbiol. 1993, 39:155-158.
62. March S.B., Ratnam S. Latex agglutination test for detection of Escherichia coli serotype O157. J. Clin. Microbiol. 1989, 27:1675-1677.
63. Corbel M.J. Recent advances in the study of Brucella antigens and their serological cross-reactions. Vet. Bull. 1985, 55:927-942.
64. Blom M., et al. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J. Clin. Microbiol. 1999, 37:2312-2316.
65. Bettelheim K.A., et al. Isolation of a Citrobacter freundii strain which carries the Escherichia coli O157 antigen. J. Clin. Microbiol. 1993, 31:760-761.
66. Reischl U., et al. Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 2002, 40:2555-2565.
67. El Sayed Zaki M., El-Adrosy H. Diagnosis of Shiga toxin-producing Escherichia coli infection, contribution of genetic amplification technique. Microbes Infect. 2007, 9:200-203.
68. Pulz M., et al. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of Shiga toxin-producing Escherichia coli in human stool specimens. J. Clin. Microbiol. 2003, 41:4671-4675.
69. Perelle S., et al. Detection by 5'-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world's most frequent clinical cases. Mol. Cell. Probes 2004, 18:185-192.
70. Perelle S., et al. Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction. J. Appl. Microbiol. 2005, 98:1162-1168.
71. Guion C.E., et al. Diagnosis of the diarrheagenic Escherichia coli using melting curve analysis of a real-time multiplex polymerase chain reaction. J. Clin. Microbiol. 2008, 46:1752-1757.
72. Persson S., et al. A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory. Clin. Microbiol. Infect. 2007, 13:516-524.
73. U.S.Department of Transportation 49 CFR parts 171-178. Guide to changes. Transporting infectious substances safely. Federal Register https://hazmatonline.phmsa.dot.gov/services/publication_document/Transporting%20Infectious%20Substances%20Safely.pdf.
74. International Air Transport Association http://www.iata.org.
75. IATA Dangerous Goods Regulation 3.6.2.2.1 Table 36 (D). [cited 2008 July 1] http://www.iata.org/NR/rdonlyres/49358D08-13D1-4333-A06B-253B1ABB6878/0/GuidanceDocDGR49mod.pdf.
76. Ahn C.K., Holt N.J., Tarr P.I. Shiga toxin-producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years?. Adv. Exp. Med. Biol. 2009, 634:1-17.
77. Summaries of infectious diseases: Escherichia coli diarrhea (including hemolytic uremic syndrome). Red Book: 26th report of the committee on infectious diseases 2003, American Academy of Pediatrics, Oak Grove Village, IL. L.K. Pickering (Ed.).
78. Teel L.D., et al. Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J. Clin. Microbiol. 2007, 45:3377-3380.
79. Park C.H., et al. Evaluation of the duopath verotoxin test for detection of Shiga toxins in cultures of human stools. J. Clin. Microbiol. 2003, 41:2650-2653.
80. Carroll K.C., et al. Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:689-692.
81. Bettelheim K.A. Development of a rapid method for the detection of verocytotoxin-producing Escherichia coli (VTEC). Lett. Appl. Microbiol. 2001, 33:31-35.
82. Beutin L., Zimmermann S., Gleier K. Evaluation of the VTEC-Screen " Seiken" test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. Diagn. Microbiol. Infect. Dis. 2002, 42:1-8.